Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: A position paper of the MeetURO Group

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2657-2666
Number of pages10
JournalFuture Oncology
Volume15
Issue number22
DOIs
Publication statusPublished - 2019

Cite this